Skip to main content
Christopher Pittenger, MD, Psychiatry, New Haven, CT, Yale-New Haven Hospital

ChristopherJohnPittengerMD

Psychiatry New Haven, CT

Director, Yale OCD Research Clinic Assistant Professor of Psychiatry Yale University

Dr. Pittenger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pittenger's full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Psychiatry, 2003 - 2007
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2003

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2005 - 2024
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Distinct but Synergistic Roles for Histone Deacetylase in the Dorsal Striatum During Habit Formation  
    Christopher Pittenger, MD, Biological Psychiatry

Authored Content

  • Distinct but Synergistic Roles for Histone Deacetylase in the Dorsal Striatum During Habit FormationAugust 2018
  • Developing Image Sets for Inducing Obsessive-Compulsive Checking SymptomsApril 2018

Press Mentions

  • A Yale Doctor Is 'Very Encouraged' That a Psychedelic Drug May Combat Anxiety and Alcoholism
    A Yale Doctor Is 'Very Encouraged' That a Psychedelic Drug May Combat Anxiety and AlcoholismSeptember 15th, 2022
  • Ceruvia Lifesciences Working on Phase 2 Psilocybin Trial for OCD
    Ceruvia Lifesciences Working on Phase 2 Psilocybin Trial for OCDMay 26th, 2022
  • AAP and the ASCI Elect New Members from the School of Medicine Faculty
    AAP and the ASCI Elect New Members from the School of Medicine FacultyApril 9th, 2021
  • Join now to see all

Grant Support

  • 5-HT1B Receptor Function In OCDNational Institute Of Mental Health2011–2012
  • CREB And The Molecular Underpinnings Of Habit LearningNational Institute Of Mental Health2008–2012
  • Pathophysiologically Realistic Mouse Models Of Neuropsychiatric Disease: TouretteNational Institute Of Mental Health2010–2011
  • Targeting Glutamate In OCD: A Placebo-Controlled, Double-Blind Augmentation TrialNational Institute Of Mental Health2009–2011
  • CREB In Declarative And Non-Declarative Memory In MouseNational Institute Of Mental Health2001

Hospital Affiliations